Work

Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension

Year: 2021

Type: review

Source: CHEST Journal

DOI: 10.1016/j.chest.2021.10.010

Authors: David F. Condon, Stuti Agarwal, Ananya Chakraborty, Natasha Auer, Rocio Vazquez, Hiral Patel, Roham T. Zamanian, Vinicio A. de Jesus Perez

Institutions: Stanford University, Stanford Medicine

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: G4362633278, A novel microfluidic platform to study exosome biology in PAH., G9000341648, Stanford Undergraduate Summer Cardiovascular Research Program, Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension, Case-Control Study of Methamphetamine in Pulmonary Arterial Hypertension, The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension

OpenAlex ID: W3207757913

FWCI: 1.324

Cites: 63

Cited by: 50

Related to: 10